日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer.

JNK通路抑制介导ER+乳腺癌对联合内分泌治疗和CDK4/6抑制剂的不敏感性

Alexandrou Sarah, Lee Christine S, Fernandez Kristine J, Wiharja Celine E, Eshraghi Leila, Reeves John, Reed Daniel A, Portman Neil, Phan Zoe, Milioli Heloisa H, Nikolic Iva, Cadell Antonia L, Croucher David R, Simpson Kaylene J, Lim Elgene, Hickey Theresa E, Millar Ewan K A, Alves Carla L, Ditzel Henrik J, Caldon C Elizabeth

Unmatched Cell Line Collections Are Not Optimal for Identification of PARP Inhibitor Response and Drug Synergies

不匹配的细胞系集合并非鉴定PARP抑制剂反应和药物协同作用的最佳选择

Phan, Zoe; Fernandez, Kristine J; Caldon, C Elizabeth

High cyclin E1 protein, but not gene amplification, is prognostic for basal-like breast cancer

细胞周期蛋白E1蛋白水平高(而非基因扩增)是基底样乳腺癌的预后指标。

Aziz, Diar; Lee, Christine; Chin, Venessa; Fernandez, Kristine J; Phan, Zoe; Waring, Paul; Caldon, C Elizabeth